Author

Marcis Leja

To screen or not to screen?
To screen or not to screen?

Marcis Leja

Is screening for premalignant gastric lesions in Europe feasable?
Is screening for premalignant gastric lesions in Europe feasable?

Marcis Leja

Research Webinar | Mission on Cancer
Research Webinar | Mission on Cancer

Marcis Leja  et al.

Conquering Cancer, Mission possible
Conquering Cancer, Mission possible

Marcis Leja

BREATH FINGERPRINT RESULTS OF GASTRIC CANCER BASED ON THE GAS CHROMATOGRAPHY-MASS SPECTROMETRY ANALYSIS
BREATH FINGERPRINT RESULTS OF GASTRIC CANCER BASED ON THE GAS CHROMATOGRAPHY-MASS SPECTROMETRY ANALYSIS

Marcis Leja  et al.

INVESTIGATION OF VOLATILOMIC SIGNATURES OF COLORECTAL TISSUES TOWARDS IDENTIFICATION OF POTENTIAL NON-INVASIVE BIOMARKERS FOR COLORECTAL CANCER
INVESTIGATION OF VOLATILOMIC SIGNATURES OF COLORECTAL TISSUES TOWARDS IDENTIFICATION OF POTENTIAL NON-INVASIVE BIOMARKERS FOR COLORECTAL CANCER

Marcis Leja  et al.

LONG NON-CODING RNA POLYMORPHISMS AND RISK OF GASTRIC CANCER AND ATROPHIC GASTRITIS
LONG NON-CODING RNA POLYMORPHISMS AND RISK OF GASTRIC CANCER AND ATROPHIC GASTRITIS

Marcis Leja  et al.

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portu
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portu

Marcis Leja  et al.

SAFETY OF THE TREATMENT OF H. PYLORI INFECTION: EXPERIENCE FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) ON 22,000 PATIENTS
SAFETY OF THE TREATMENT OF H. PYLORI INFECTION: EXPERIENCE FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) ON 22,000 PATIENTS

Marcis Leja  et al.

ANALYSIS OF VOLATILE ORGANIC COMPOUNDS EMITTED BY GASTRIC JUICE
ANALYSIS OF VOLATILE ORGANIC COMPOUNDS EMITTED BY GASTRIC JUICE

Marcis Leja  et al.

EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE
EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE

Marcis Leja  et al.

FACTORS ASSOCIATED WITH GASTRIC ATROPHY MISSED” BY SEROLOGIC TESTING
FACTORS ASSOCIATED WITH GASTRIC ATROPHY MISSED” BY SEROLOGIC TESTING

Marcis Leja  et al.

BIOPSY SAMPLING IN UPPER GASTROINTESTINAL ENDOSCOPY - A SURVEY FROM TEN TERTIARY REFERRAL CENTRES ACROSS EUROPE
BIOPSY SAMPLING IN UPPER GASTROINTESTINAL ENDOSCOPY - A SURVEY FROM TEN TERTIARY REFERRAL CENTRES ACROSS EUROPE

Marcis Leja  et al.

SEROLOGICALLY DETERMINED GASTRIC ATROPHY ASSOCIATED WITH LIFESTYLE, DIETARY FACTORS AND HELICOBACTER PYLORI STATUS
SEROLOGICALLY DETERMINED GASTRIC ATROPHY ASSOCIATED WITH LIFESTYLE, DIETARY FACTORS AND HELICOBACTER PYLORI STATUS

Marcis Leja  et al.

FIRST-LINE H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 24,882 CASES OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
FIRST-LINE H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 24,882 CASES OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marcis Leja  et al.

EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020
EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020

Marcis Leja  et al.

EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marcis Leja  et al.

HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marcis Leja  et al.

EFFECTIVENESS OF TREATMENTS AGAINST HELICOBACTER PYLORI ACCORDING TO RESISTANCE TO CLARITHROMYCIN: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF TREATMENTS AGAINST HELICOBACTER PYLORI ACCORDING TO RESISTANCE TO CLARITHROMYCIN: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Marcis Leja  et al.

IMPACT OF HELICOBACTER PYLORI CLARITHROMYCIN RESISTANCE ON THE TREATMENT EFFECTIVENESS: DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
IMPACT OF HELICOBACTER PYLORI CLARITHROMYCIN RESISTANCE ON THE TREATMENT EFFECTIVENESS: DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marcis Leja  et al.

Item 1 - 20 / 42
1
2 3